Cargando…
Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens
From the peripheral blood of the melanoma patient (AV), we derived cytolytic T lymphocyte (CTL) clones that lysed the autologous tumor line SK-MEL-29, but not autologous EBV-B cells, K562, and other tumor targets. By immunoselection experiments it was shown that the CTL clones recognized at least th...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189434/ https://www.ncbi.nlm.nih.gov/pubmed/2788708 |
Ejemplares similares
-
Cytotoxicity of Histocompatibility Leukocyte Antigen–DR8–restricted CD4(+) Killer T Cells against Human Autologous Squamous Cell Carcinoma
por: Miyazaki, Akihiro, et al.
Publicado: (1997) -
Antigen valence determines the binding of nominal antigen to cytolytic T cell clones
Publicado: (1985) -
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes
Publicado: (1994) -
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
Publicado: (1995) -
Specificity of T cell clones for antigen and autologous major histocompatibility complex products determines specificity for foreign major histocompatibility complex products
Publicado: (1983)